A Phase II study of Gefitinib in Patients with Advanced Salivary Gland Cancers

od Jakob, John A., Kies, Merrill S., Glisson, Bonnie S., Kupferman, Michael E., Liu, Diane D., Lee, J. Jack, El-Naggar, Adel K., Gonzalez-Angulo, Ana M., Blumenschein, George R.
Izdano u Head Neck (2015)

NRAS Mutation Status is an Independent Prognostic Factor in Metastatic Melanoma

od Jakob, John A., Bassett, Roland L., Ng, Chaan S., Curry, Jonathan L., Joseph, Richard W., Alvarado, Gladys C., Rohlfs, Michelle L., Richard, Jessie, Gershenwald, Jeffrey E., Hwu, Patrick, Kim, Kevin B., Lazar, Alexander J., Davies, Michael A.
Izdano 2011